This biopharmaceutical company has 14 marketed products and over 4200 employees on four continents. Gilead had almost $8 billion in revenues in 2010.
Gilead Sciences consistently ranks among top performers in the Wealth Creation Index. Among the consistent top performers, Mike Burdi, Applied Finance Group senior analyst, finds a common thread: “Do your customers care whether you stay in business? It’s one thing to say that one is customer-focused; most claim to be as a matter of course. But would your customers really miss not having access to what you offer?” For Gilead customers, that answer is yes.
| Score | 2010 Score | % Change In Score | Market Value/Invested Capital | Three-Year EM | EM Change | Mgmt Quality |
|---|---|---|---|---|---|---|
| 92.8 | 86.7 | 7.0% | B | A | A | A |
On the latest episode of Corporate Competitor Podcast, Kane, who also served as president of…
In a world where business increasingly resembles the pit wall—fast, visible and unforgiving—Claire Williams' lessons…
Chief Executive’s latest poll finds CEO outlook improving amid worry about a potential economic slowdown.
If your feed isn’t carrying your real thinking, it’s not just noise—it’s costing you credibility…
Dominique Bastien, founder of The Gondola Shop, shares how she stumbled into—and created—a niche industry…
A tech entrepreneur who built and sold two companies argues that the secret to great…